RLYB · Rallybio Corp
$16.99
+0.03 (+0.18%)
At close · Aug 14
Market Cap
$90.23M
Shares
5.31M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-06 | 2026-06-30 | |
| 8-K | 2026-06-01 | 2026-05-31 | |
| 10-Q | 2026-05-13 | 2026-03-31 | |
| 8-K | 2026-05-04 | 2026-05-03 | |
| 8-K | 2026-03-31 | — | |
| 10-K | 2026-03-16 | 2025-12-31 | |
| 8-K | 2026-03-02 | 2026-03-01 | |
| 8-K | 2026-01-29 | 2026-01-26 | |
| DEF 14A | 2026-01-02 | 2026-01-26 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-08-29 | 2025-08-26 | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-07-08 | — | |
| 8-K | 2025-06-27 | 2025-06-25 | |
| 8-K | 2025-05-16 | 2025-05-13 | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| 8-K | 2025-04-08 | — | |
| DEF 14A | 2025-04-07 | 2024-12-31 | |
| 8-K | 2025-03-13 | — | |
| 10-K | 2025-03-13 | 2024-12-31 | |
| 8-K | 2025-03-13 | — | |
| 8-K | 2025-02-25 | 2025-02-24 | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-09-17 | 2024-09-16 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-07-23 | — | |
| 8-K | 2024-05-21 | 2024-05-15 | |
| 8-K | 2024-05-09 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| DEF 14A | 2024-04-11 | 2023-12-31 | |
| 8-K | 2024-04-10 | 2024-04-09 | |
| 8-K | 2024-03-12 | — | |
| 10-K | 2024-03-12 | 2023-12-31 | |
| 8-K | 2024-02-06 | — | |
| 8-K | 2023-12-20 | — | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-11-09 | — | |
| 8-K | 2023-08-08 | — | |
| 10-Q | 2023-08-08 | 2023-06-30 | |
| 8-K | 2023-06-29 | 2023-06-28 | |
| 8-K | 2023-05-22 | 2023-05-17 | |
| 10-Q | 2023-05-09 | 2023-03-31 | |
| 8-K | 2023-05-09 | — | |
| DEF 14A | 2023-04-10 | 2023-05-17 | |
| 8-K | 2023-03-06 | — |
Showing 1–50 of 74 filings
Key facts
CIK
1739410
CUSIP
75120L209
13F (30d)
42 filings
40 filers
Visit website
Investor relations